View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 02 27

Cash bond markets are overstating MOH's credit risk with a YTW of 6.033% relative to an Intrinsic YTW of 5.103%, while CDS markets are slightly overstating credit risk with a CDS of 152bps relative to an Intrinsic CDS of 83bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate BehaviorTM analysis highlights mostly negative signals for credit holders. As a...

Molina Healthcare Inc: 1 director

A director at Molina Healthcare Inc sold 1,000 shares at 401.050USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2024 01 17

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 01 09

Credit markets are overstating MOH's credit risk with a YTW of 5.895% and a CDS of 143bps, relative to an Intrinsic YTW of 4.665% and an Intrinsic CDS of 76bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As a positive, most management members are material owners of MOH equity...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500, Nasdaq 100 Back at Support Our expectations since late September remain unchanged; equities are not yet out of the woods, but as long as the S&P 500 is above 4165-4200, most signs point to this being a normal pullback within the ongoing bullish trend in SPX. Similarly, the Nasdaq 100 (QQQ) is testing support at $350-$355 (the 4-month bull flag/falling wedge pattern). The Russell 2000 is also approaching 1+ year support at 1640. Breakdowns would be our cue to get defensive, as it would ...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 10 11

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 10 09

Cash bond markets are materially overstating MOH's credit risk with a YTW of 7.387% relative to an Intrinsic YTW of 5.587%, while CDS markets are overstating credit risk with a CDS of 176bps relative to an Intrinsic CDS of 78bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As ...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 07 19

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Molina Healthcare, Inc.: Molina’s acquisition of Bright Health's Medic...

The Bright House Medicare acquisition will add to Molina's earnings and provide cost-synergy opportunities.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 07 03

Cash bond markets are materially overstating MOH's credit risk with a YTW of 6.496% relative to an Intrinsic YTW of 4.816%, while CDS markets are overstating credit risk with a CDS of 194bps relative to an Intrinsic CDS of 85bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. Tha...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 04 12

Cash bond markets are materially overstating MOH's credit risk with a YTW of 6.138% relative to an Intrinsic YTW of 4.428%, while CDS markets are overstating credit risk with a CDS of 195bps relative to an Intrinsic CDS of 91bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. Tha...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2022 12 28

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2022 12 20

Credit markets are overstating MOH's credit risk with a YTW of 5.940% and a CDS of 201bps, relative to an Intrinsic YTW of 4.560% and an Intrinsic CDS of 84bps. Furthermore, Moody's is grossly overstating the firm's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. That said, most management members are material owners of MOH equit...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2022 09 28

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2022 09 28

Credit markets are materially overstating MOH's credit risk with a YTW of 6.156% and a CDS of 228bps, relative to an Intrinsic YTW of 4.536% and an Intrinsic CDS of 78bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. That said, most management members are material owners of MOH...

Molina Healthcare, Inc.: Molina’s My Choice Wisconsin acquisition is c...

The My Choice Wisconsin will add to Molina's earnings and provide cost-synergy opportunities.

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2022 07 13

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2022 07 12

Credit markets are materially overstating credit risk, with a cash bond YTW of 6.241% and a CDS of 279bps relative to an Intrinsic YTW of 3.941% and an Intrinsic CDS of 100bps. Meanwhile, Moody's is grossly overstating the firm's fundamental credit risk, with its Ba3 credit rating eight notches lower than Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. That said, management members are material owners of MOH equity re...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2022 04 19

Generac Holdings Inc. (GNRC) has a dominant and growing market position for backup power generation and storage, a trend that is likely to grow for years. Uniform Accounting highlights that the market is not pricing in these tailwinds, and Generac's potential to grow and expand returns faster signal the potential for equity upside. Generac owns a 75% market share for household backup generators, a market with low penetration and accelerating demand. With households and businesses relying on...

Valens Research
  • Valens Research

MOH - Embedded Expectations Analysis - 2022 04 18

Molina Healthcare, Inc. (MOH) currently trades near corporate but above historical averages relative to Uniform earnings, with a 23.5x Uniform P/E (Fwd. V/E%u2019). At these levels, markets are pricing in expectations for Uniform ROA to expand to 22%, accompanied by 5% Uniform asset growth. Meanwhile, analysts expect Uniform ROA to improve to 24% in 2023, accompanied by 5% Uniform asset growth. If sustained going forward, these levels would imply a stock price closer to $378, representing app...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch